Breaking News Instant updates and real-time market news.

ISRG

Intuitive Surgical

$558.06

-0.64 (-0.11%)

15:00
03/15/19
03/15
15:00
03/15/19
15:00

Intuitive Surgical clearance expands addressable market, says Piper Jaffray

After Intuitive Surgical announced it has received clearance for the da Vinci SP surgical system for use in certain transoral otolaryngology procedures in adults, Piper Jaffray analyst JP McKim said a move into the Ear, Nose and Throat space should be market expansive, adding that his checks suggest "the ENT community is excited to get the opportunity to use robotics." McKim reiterated an Overweight rating and $625 price target on Intuitive Surgical shares.

  • 18

    Apr

  • 25

    Apr

ISRG Intuitive Surgical
$558.06

-0.64 (-0.11%)

02/14/19
FBCO
02/14/19
NO CHANGE
Target $151
FBCO
Outperform
Auris strengthens Johnson & Johnson's robotics program, says Credit Suisse
Credit Suisse analyst Vamil Divan says the Auris Health deal brings to Johnson & Johnson (JNJ) an attractive collection of robotic surgery assets, including 3 FDA-cleared robotic systems, a pipeline of additional applications and technologies, as well as significant robotics IP from both Auris and Hansen. Auris also brings substantial R&D and commercialization expertise related to robotic surgery systems, not least of which is Fred Moll - founder of Intuitive Surgical (ISRG) -, who is expected to remain with the program for the next 2-3 years, if not longer, the analyst adds. Divan reiterates an Outperform rating and $151 target on Johnson & Johnson, and views the Auris deal as an incremental near-term positive, with potentially significant long-term positive impact as the company's robotic surgery strategy unfolds.
02/28/19
RBCM
02/28/19
NO CHANGE
RBCM
Sector Perform
RBC says FDA safety communication could put pressure on Intuitive Surgical
RBC Capital analyst Brandon Henry noted that the FDA issued a safety communication regarding the use of robotics in cancer-related women's health surgeries, which he believes could put some incremental pressure on part of Intuitive Surgical's U.S. business with gynecologists, particularly the cancer-related hysterectomy portion. While he said the potential impact should be manageable, Henry thinks it is prudent to model a decline in Intuitive's U.S. cancer-related hysterectomies business in 2019, the analyst stated. He maintains a Sector Perform rating on Intuitive Surgical shares.
02/28/19
PIPR
02/28/19
NO CHANGE
PIPR
Overweight
Piper sees mimimal impact today on Intuitive Surgical shares from FDA statement
After the FDA issued a safety communication regarding the use of robotically-assisted surgical devices in Women's Health, including mastectomy and other cancer-related surgeries, Piper Jaffray analyst JP McKim said he expects minimal impact to ISRG today. While developments like these in women's health are worth monitoring, the biggest drivers for Intuitive continues to be general surgery and growth outside the U.S., said McKim. Additionally, the FDA is not saying robotic surgery is worse, just that there is limited safety and effectiveness data on long term outcomes for the prevention or treatment of cancer, noted McKim, who keeps an Overweight rating on the stock.
03/04/19
PIPR
03/04/19
NO CHANGE
Target $625
PIPR
Overweight
Early feedback on Intuitive Surgical's SP largely positive, says Piper Jaffray
After speaking with call with a physician from Hackensack University Medical Center, one of the early adopters of the company's SP robotic system, Piper Jaffray analyst JP McKim reiterates an Overweight rating on Intuitive Surgical with a $625 price target. Early feedback was largely positive, McKim tells investors in a research note. He says that while SP will be more cannibalistic in urology, it will "open up the door into new specialties like ENT and fuel additional growth to General Surgery." The analyst believes that if SP can get the same clinical outcomes as multiport systems, patients are going to be drawn to its single incision surgery.

TODAY'S FREE FLY STORIES

DIA

Diamonds Fund ETF

$271.56

-0.73 (-0.27%)

08:17
07/22/19
07/22
08:17
07/22/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$297.17

-1.69 (-0.57%)

08:17
07/22/19
07/22
08:17
07/22/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$27.93

-0.145 (-0.52%)

08:17
07/22/19
07/22
08:17
07/22/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLRX

Salarius Pharmaceuticals

$0.62

0.0155 (2.56%)

, FLKS

Flex Pharma

$0.00

(0.00%)

08:17
07/22/19
07/22
08:17
07/22/19
08:17
Hot Stocks
Salarius Pharmaceuticals closes strategic merger with Flex Pharma »

Salarius Pharmaceuticals…

SLRX

Salarius Pharmaceuticals

$0.62

0.0155 (2.56%)

FLKS

Flex Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$116.43

-0.04 (-0.03%)

08:16
07/22/19
07/22
08:16
07/22/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$190.96

-1.57 (-0.82%)

08:16
07/22/19
07/22
08:16
07/22/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
07/22/19
07/22
08:16
07/22/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
07/22/19
07/22
08:16
07/22/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$73.03

-0.07 (-0.10%)

08:15
07/22/19
07/22
08:15
07/22/19
08:15
Recommendations
Restaurant Brands analyst commentary  »

Restaurant Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$4.04

0.1 (2.54%)

08:15
07/22/19
07/22
08:15
07/22/19
08:15
Downgrade
New Age Beverages rating change  »

New Age Beverages…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
07/22/19
07/22
08:15
07/22/19
08:15
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

June Chicago Fed National…

DCTH

Delcath Systems

$0.00

(0.00%)

08:14
07/22/19
07/22
08:14
07/22/19
08:14
Hot Stocks
Delcath Systems announces results of single center study of PHP Therapy »

Delcath Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

08:12
07/22/19
07/22
08:12
07/22/19
08:12
Recommendations
Methanex analyst commentary  »

Methanex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

NVR

NVR

$3,527.32

41.32 (1.19%)

08:12
07/22/19
07/22
08:12
07/22/19
08:12
Recommendations
NVR analyst commentary  »

NVR price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

MDT

Medtronic

$100.79

-0.565 (-0.56%)

08:12
07/22/19
07/22
08:12
07/22/19
08:12
Hot Stocks
Medtronic, Viz.ai partner for adoption of AI software in U.S. stroke centers »

Medtronic and Viz.ai have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

ADAP

Adaptimmune

$3.29

-0.14 (-4.08%)

08:10
07/22/19
07/22
08:10
07/22/19
08:10
Hot Stocks
Adaptimmune initiates radiation sub-study of ADP-A2M4 trial »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 29

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

ITRI

Itron

$59.85

0.41 (0.69%)

08:09
07/22/19
07/22
08:09
07/22/19
08:09
Hot Stocks
Itron appoints Tom Deitrich as CEO »

Itron announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

VRTX

Vertex

$174.07

-3.9 (-2.19%)

08:09
07/22/19
07/22
08:09
07/22/19
08:09
Hot Stocks
Vertex submits VX-445 NDA to FDA »

Vertex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

DFS

Discover

$81.79

0.14 (0.17%)

, PYPL

PayPal

$118.65

-1.22 (-1.02%)

08:08
07/22/19
07/22
08:08
07/22/19
08:08
Hot Stocks
Discover appoints Wanji Walcott as Chief Legal Officer and General Counsel »

Wanji Walcott joined…

DFS

Discover

$81.79

0.14 (0.17%)

PYPL

PayPal

$118.65

-1.22 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 13

    Nov

NTWK

NetSol Technologies

$5.77

-0.11 (-1.87%)

08:08
07/22/19
07/22
08:08
07/22/19
08:08
Hot Stocks
NetSol wins multi-million dollar contract with UK vehicle finance company »

NETSOL Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBPH

Theravance Biopharma

$17.55

-0.79 (-4.31%)

08:08
07/22/19
07/22
08:08
07/22/19
08:08
Hot Stocks
Theravance Biopharma presents new data from Phase 2 study of ampreloxetine »

Theravance Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

PGNX

Progenics

$5.27

-0.07 (-1.31%)

08:08
07/22/19
07/22
08:08
07/22/19
08:08
Hot Stocks
Velan Capital confirms Progenics' stockholders endorse change »

Velan Capital, one of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BMRC

Bank of Marin

$42.37

0.05 (0.12%)

08:07
07/22/19
07/22
08:07
07/22/19
08:07
Earnings
Bank of Marin reports Q2 EPS 60c, consensus 60c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

PMBC

Pacific Mercantile Bancorp

$8.19

-0.08 (-0.97%)

08:07
07/22/19
07/22
08:07
07/22/19
08:07
Earnings
Pacific Mercantile Bancorp reports Q2 EPS 12c, two est. 13c »

Reports Q2 CET1 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$44.40

-0.03 (-0.07%)

, BOX

Box

$16.75

-0.23 (-1.35%)

08:06
07/22/19
07/22
08:06
07/22/19
08:06
Hot Stocks
Morgan Stanley launches document sharing portal powered by Box »

Morgan Stanley (MS)…

MS

Morgan Stanley

$44.40

-0.03 (-0.07%)

BOX

Box

$16.75

-0.23 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.